LEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme

Deep News

02/23

LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million.

Following the recent quarterly review results announced by Hang Seng Indexes Company, LEADS BIOLABS has been included in the Hang Seng Composite Index. All changes will take effect after the market close on March 6 and will be implemented starting March 9. A research report from CICC indicated that LEADS BIOLABS could potentially be added to the Southbound Stock Connect scheme in March. Meanwhile, Western Securities noted that, considering the company's multiple clinical data catalysts expected in 2026, a commercial inflection point is anticipated by 2027.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1199865714"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1199865714\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1199865714?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-23 15:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199865714","market":"sh","top_or_hot":-1,"title":"LEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme","media":"Deep News","content":"<p>LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million.</p>\n<p>Following the recent quarterly review results announced by Hang Seng Indexes Company, LEADS BIOLABS has been included in the Hang Seng Composite Index. All changes will take effect after the market close on March 6 and will be implemented starting March 9. A research report from CICC indicated that LEADS BIOLABS could potentially be added to the Southbound Stock Connect scheme in March. Meanwhile, Western Securities noted that, considering the company's multiple clinical data catalysts expected in 2026, a commercial inflection point is anticipated by 2027.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-02-23 15:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million.</p>\n<p>Following the recent quarterly review results announced by Hang Seng Indexes Company, LEADS BIOLABS has been included in the Hang Seng Composite Index. All changes will take effect after the market close on March 6 and will be implemented starting March 9. A research report from CICC indicated that LEADS BIOLABS could potentially be added to the Southbound Stock Connect scheme in March. Meanwhile, Western Securities noted that, considering the company's multiple clinical data catalysts expected in 2026, a commercial inflection point is anticipated by 2027.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"","article_id":"1199865714","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199865714","pubTimestamp":1771830019,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million. Following the recent quarterly review...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK1161":"生物科技","HK0000252152.HKD":"易方达 (香港) 中国股票股息基金A 类 (累积) 港元","VT":"世界全股市ETF-Vanguard","VXUS":"国际股票ETF-Vanguard","BK4588":"碎股","09887":"维立志博-B","HK0000500386.USD":"易方达 (香港) 中国股票股息基金A 类 (累积) 美元","HK0000252160.HKD":"易方达 (香港) 中国股票股息基金A 类 (分派) 港元"},"translate_title":"领先BIOLABS-B股价午后飙升6%，因可能纳入港股通交易计划","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VT":1,"09887":1,"VXUS":1},"content_text":"LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million.\nFollowing the recent quarterly review results announced by Hang Seng Indexes Company, LEADS BIOLABS has been included in the Hang Seng Composite Index. All changes will take effect after the market close on March 6 and will be implemented starting March 9. A research report from CICC indicated that LEADS BIOLABS could potentially be added to the Southbound Stock Connect scheme in March. Meanwhile, Western Securities noted that, considering the company's multiple clinical data catalysts expected in 2026, a commercial inflection point is anticipated by 2027.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}